Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:49:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant revisions regarding the clinical study of losmapimod for COVID-19, including updates to the study's design and details about the treatment protocol. Key information about the study's hypothesis, inclusion and exclusion criteria, and the investigational model has been added, while previous detailed descriptions have been removed.
    Difference
    33%
    Check dated 2025-04-16T01:46:28.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:27:13.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:43:40.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:17:30.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:40:25.000Z thumbnail image

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.